Today at the @amdiabetesassn.bsky.social meeting: detailed results of multiple late-stage studies of an investigational therapy for type 2 diabetes that could simplify insulin management. Read more: e.lilly/4efejLW #ADA2025

Results of the first late-stage clinical study of a potential new type 2 diabetes pill were presented today at the American Diabetes Association meeting and published in the @nejm.org . Read more: e.lilly/3ZFGVb6

New today: the full results of a study comparing our obesity medicine to another therapy were published in the @nejm.org and presented at the European Congress on Obesity. Read more: e.lilly/435GwQ8

Interested in challenging misperceptions of disease representation in TV and film? How about understanding Alzheimer’s or equity in obesity care? Do you wonder about the potential of genetic medicine or AI in healthcare? Join us at #SXSW to learn more: https://e.lilly/4h7n0I0#SXSW#WeAreLilly #sponsor